# DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

NDC: 72205-435
Generic name: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260406

FDA application: ANDA211479

## Active ingredients

- DAPAGLIFLOZIN: 5 mg/1
- METFORMIN HYDROCHLORIDE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-435"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-435
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f890458-be94-4baf-b606-83a097e1e23e